Raptiva, which had 2008 sales of $108 million in the United States, has been linked to a brain infection.
Original post by By REUTERS
Posts Related to Genentech Starts Pulling Back Psoriasis Drug
F.D.A. Panel Supports Avastin to Treat Brain Tumor
Preliminary studies of a blockbuster drug from Roche’s Genentech unit are strong enough to speed its approval for brain cancer, federal cancer experts said. Original ...
N.F.L. Sees Decline in Drug-Resistant Infection
N.F.L. players have contracted 33 cases of the virulent skin infection known as MRSA over the past three years, a recent survey has found, a ...
Morning Rounds: Everyday Poisonings, Psoriasis Drug Deaths and Wider Use of Statins
Health news from around the Web. Original post by By NICHOLAS BAKALAR
Roche’s Genentech Bid Turns Hostile
Roche said it would pay a lower price than it had offered last July for the 44 percent of Genentech it does not already own ...
Brain Power: Brain Researchers Open Door to Editing Memory
An influx of money and talent into neuroscience has led to an experimental drug that could block certain memories. Original post by By BENEDICT CAREY